Delisle MJ - Search Results

1

Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.

Sobol H, Narod SA, Nakamura Y, Boneu A, Calmettes C, Chadenas D, Charpentier G, Chatal JF, Delepine N, Delisle MJ. Sobol H, et al. Among authors: delisle mj. N Engl J Med. 1989 Oct 12;321(15):996-1001. doi: 10.1056/NEJM198910123211502. N Engl J Med. 1989. PMID: 2571086

2

Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.

Baulieu JL, Guilloteau D, Delisle MJ, Perdrisot R, Gardet P, Delépine N, Baulieu F, Dupont JL, Talbot JN, Coutris G, et al. Baulieu JL, et al. Among authors: delisle mj. Cancer. 1987 Nov 1;60(9):2189-94. doi: 10.1002/1097-0142(19871101)60:9<2189::aid-cncr2820600913>3.0.co;2-c. Cancer. 1987. PMID: 2894239

3

[Medullary cancer of the thyroid and multiple endocrine neoplastic syndromes].

Delisle MJ. Delisle MJ. Rev Prat. 1992 Apr 1;42(7):845-50. Rev Prat. 1992. PMID: 1351314 French.

4

Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.

Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE, Schlumberger M, Romeo G, Canzian F. Lesueur F, et al. Among authors: delisle mj. J Clin Endocrinol Metab. 1999 Jun;84(6):2157-62. doi: 10.1210/jcem.84.6.5798. J Clin Endocrinol Metab. 1999. PMID: 10372725

5

High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.

Vistelle R, Grulet H, Gibold C, Chaufour-Higel B, Delemer B, Fay R, Delisle MJ, Caron J. Vistelle R, et al. Among authors: delisle mj. Clin Endocrinol (Oxf). 1991 Feb;34(2):133-8. doi: 10.1111/j.1365-2265.1991.tb00283.x. Clin Endocrinol (Oxf). 1991. PMID: 1673649

6

[Medullary thyroid cancers. Prognostic factors of nonassociated sporadic forms. Therapeutic implications].

Gardet P, Rougier P, Laplanche A, Delisle MJ, Caillou B, Schlumberger M, Travagli JP, Parmentier C. Gardet P, et al. Among authors: delisle mj. Bull Cancer. 1984;71(3):188-91. Bull Cancer. 1984. PMID: 6487827 French. No abstract available.

7

Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.

Krempf M, Lumbroso J, Mornex R, Brendel AJ, Wemeau JL, Delisle MJ, Aubert B, Carpentier P, Fleury-Goyon MC, Gibold C, et al. Krempf M, et al. Among authors: delisle mj. J Clin Endocrinol Metab. 1991 Feb;72(2):455-61. doi: 10.1210/jcem-72-2-455. J Clin Endocrinol Metab. 1991. PMID: 1991814 Clinical Trial.

8

Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population.

Hannequin P, Liehn JC, Delisle MJ. Hannequin P, et al. Among authors: delisle mj. Cancer. 1986 Oct 15;58(8):1749-55. doi: 10.1002/1097-0142(19861015)58:8<1749::aid-cncr2820580828>3.0.co;2-q. Cancer. 1986. PMID: 3756796

9

Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.

Krempf M, Lumbroso J, Mornex R, Brendel AJ, Wemeau JL, Delisle MJ, Aubert B, Carpentier P, Fleury-Goyon MC, Gibold C, et al. Krempf M, et al. Among authors: delisle mj. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):284-7. J Nucl Biol Med (1991). 1991. PMID: 1823837 Clinical Trial.

10

Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.

Schvartz C, Gibold C, Vuillemin B, Delisle MJ. Schvartz C, et al. Among authors: delisle mj. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):305-7. J Nucl Biol Med (1991). 1991. PMID: 1823842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters